Canada markets closed

Affimed N.V. (AFMD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.9100-0.0800 (-4.02%)
At close: 04:00PM EST
1.8100 -0.10 (-5.24%)
After hours: 07:29PM EST
Full screen
Loading interactive chart...
  • GlobeNewswire

    Affimed to Host Investor Event Highlighting AFM13 Clinical Development at 2022 ASH Annual Meeting

    Review of clinical data and development plans for AFM13 in hematologic malignanciesLive event and webcast on Saturday, December 10 at 4:00 p.m. CST HEIDELBERG, Germany,, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it will host an Investor Event on December 10 during the 64th American Society of Hematology (ASH) Annu

  • Motley Fool

    Why Shares of Affimed Fell Thursday

    Shares of German immuno-oncology company Affimed Therapeutics (NASDAQ: AFMD) were down a little more than 15% on Thursday afternoon. There was no big news from the biotech company, but clinical-stage biotechs are considered riskier stocks than most, and with the markets dropping in general on Thursday, Affimed's shares took a hit. Investors are waiting to hear next month how two clinical trials are faring for one of the company's lead therapies in AFM13.

  • Simply Wall St.

    Affimed Third Quarter 2022 Earnings: Beats Expectations

    Affimed ( NASDAQ:AFMD ) Third Quarter 2022 Results Key Financial Results Revenue: €15.0m (up 69% from 3Q 2021). Net...